Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/EJE-09-0123
European Journal of Endocrinology, Vol 161, Issue 1, 171-177
Copyright © 2009 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
EJE-09-0123v1
161/1/171    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bogaert, V.
Right arrow Articles by Kaufman, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bogaert, V.
Right arrow Articles by Kaufman, J.-M.

CLINICAL STUDY

Small effect of the androgen receptor gene GGN repeat polymorphism on serum testosterone levels in healthy men

Veerle Bogaert1, Griet Vanbillemont1, Youri Taes1, Dirk De Bacquer2,3, Ellen Deschepper2,3, Kristel Van Steen4,5,6 and Jean-Marc Kaufman1

1 Department of Endocrinology, 9 K12 I.E, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium2 , Department of Public Health3 Biostatistical Unit, Ghent University, Ghent, Belgium4 Montefiore Institute – Bioinformatics, University of Liège, Liège, Belgium5 StepGen cvba, Merelbeke, Belgium6 Department of Medical Genetics, Ghent University, Ghent, Belgium

(Correspondence should be addressed to J-M Kaufman; Email: jean.kaufman{at}ugent.be)

Objective: The human androgen receptor (AR) contains a polyglutamine and a polyglycine stretch which are highly polymorphic and are coded respectively by a CAG and GGN repeat in exon 1 of the AR gene. Although the in vitro studies indicated a possible effect of the GGN repeat polymorphism on the AR gene transcription and clinical observations suggest that it might modulate the androgen action, its functional significance remains unclear. We wanted to assess whether the GGN repeat affects the serum testosterone levels in healthy men, which is the expected outcome through feedback regulation if it influences androgen action as has been shown to be the case for the CAG repeat.

Design and patients: A population based cross-sectional cohort study including 1476 healthy young, middle-aged, and elderly men.

Measurement: Testosterone and LH levels were determined by immunoassay; free testosterone (FT) levels were calculated. Genotyping of the GGN repeat was performed using the sequencing technique.

Results: The GGN repeat number was significantly associated with circulating testosterone and FT levels (P=0.017 and P=0.013 respectively). However, taking into account that age, body mass index, and CAG are already in the regression model, the GGN repeat could explain only a small part of the variation of both testosterone and FT.

Conclusion: To our knowledge, this study is the first to demonstrate a significant positive association between the GGN repeat and androgen levels in a large cohort of healthy men. Although the present study thus adds credence to the view that the polyglycine tract in the AR can modulate AR action, this effect appears to be only small so that its clinical relevance remains questionable.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 European Society of Endocrinology.